Connect with us

Technology

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

Published

on

LAUSANNE, Switzerland, Jan. 2, 2025 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 20,000 of the Company’s common shares to two new employees on January 2, 2025 (each, a “Grant”).

The Grants were offered as material inducement to the employees’ employment. The grants were approved by the Compensation Committee of the Company’s Board of Directors pursuant to the Company’s Inducement Plan to motivate and reward the recipients to perform at the highest levels and contribute significantly to the success of the Company. The Grants were made in reliance on the employment inducement exemption under the NYSE’s Listed Company Manual Rule 303A.08.

The Company is issuing this press release pursuant to Rule 303A.08. The Grants shall vest and become exercisable 25% on the first anniversary of the grant date, and 1/48th of the aggregate number of shares subject to the award on each monthly anniversary of the grant date thereafter, such that the entire award will be vested as of the fourth anniversary of the grant date, subject to continued employment with the Company.

About ADC Therapeutics

ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs). The Company is advancing its proprietary ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

ADC Therapeutics’ CD19-directed ADC ZYNLONTA (loncastuximab tesirine-lpyl) received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy. In addition to ZYNLONTA, ADC Therapeutics has multiple ADCs in ongoing clinical and preclinical development.

ADC Therapeutics is based in Lausanne (Biopôle), Switzerland, and has operations in London and New Jersey. For more information, please visit https://adctherapeutics.com/ and follow the Company on LinkedIn.

ZYNLONTA® is a registered trademark of ADC Therapeutics SA.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “would”, “expect”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “future”, “continue”, or “appear” or the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to: the expected cash runway into mid-2026 the Company’s ability to grow ZYNLONTA® revenue in the United States; the ability of our partners to commercialize ZYNLONTA® in foreign markets, the timing and amount of future revenue and payments to us from such partnerships and their ability to obtain regulatory approval for ZYNLONTA® in foreign jurisdictions; the timing and results of the Company’s or its partners’ research and development projects or clinical trials including LOTIS 5 and 7, ADCT 602 as well as early research in certain solid tumors with different targets, linkers and payloads; the timing and results of investigator-initiated trials including those studying FL and MZL and the potential regulatory and/or compendia strategy and the future opportunity; the timing and outcome of regulatory submissions for the Company’s products or product candidates; actions by the FDA or foreign regulatory authorities; projected revenue and expenses; the Company’s indebtedness, including Healthcare Royalty Management and Blue Owl and Oaktree facilities, and the restrictions imposed on the Company’s activities by such indebtedness, the ability to comply with the terms of the various agreements and repay such indebtedness and the significant cash required to service such indebtedness; and the Company’s ability to obtain financial and other resources for its research, development, clinical, and commercial activities. Additional information concerning these and other factors that may cause actual results to differ materially from those anticipated in the forward-looking statements is contained in the “Risk Factors” section of the Company’s Annual Report on Form 10-K and in the Company’s other periodic and current reports and filings with the U.S. Securities and Exchange Commission. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document.

CONTACTS:

Investors
Marcy Graham
ADC Therapeutics
Marcy.Graham@adctherapeutics.com
+1 650-667-6450

Media
Nicole Riley
ADC Therapeutics
Nicole.Riley@adctherapeutics.com
+1 862-926-9040

View original content to download multimedia:https://www.prnewswire.com/news-releases/adc-therapeutics-makes-grants-to-new-employees-under-inducement-plan-302338599.html

SOURCE ADC Therapeutics SA

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

The Groundbreaking Lucid Gravity to Leverage Panasonic Energy’s Latest-Generation High-Performance EV Batteries

Published

on

By

LAS VEGAS and NEWARK, Calif., Jan. 6, 2025 /PRNewswire/ — Panasonic Energy Co., Ltd., a global leader in the battery industry, and Lucid Group, Inc. (NASDAQ: LCID), maker of the world’s most advanced electric vehicles, today announced the highly anticipated Lucid Gravity Grand Touring will be powered by Panasonic Energy’s lithium-ion EV battery cells. With an EPA-estimated range of up to 450 miles1 from a battery pack that is up to 40 percent smaller than competitors’, the collaborative efforts between Panasonic and Lucid have helped deliver an SUV with a previously impossible combination of outstanding range, performance and interior space.

Lucid Gravity is a groundbreaking new class of SUV, conceived from the ground up without compromise. Enabled by Lucid’s revolutionary technology, Lucid Gravity provides the interior space and practicality of a full-size SUV with up to 120 cubic feet of total usable cargo space2, all contained inside the exterior footprint of a mid-size SUV. As a result, it provides a sophisticated space for up to seven adults, game-changing versatility, and an unparalleled driving experience. The Lucid Gravity Grand Touring offers 828 horsepower, is capable of 0-60 in under 3.5 seconds, and has an EPA-rated range of up to 450 miles.

These impressive features are enabled in part by Panasonic Energy’s latest-generation high performing 2170 cylindrical lithium-ion battery cells, which offer an energy density of above 800Wh/L (watt-hours per liter), an industry-leading achievement. These high-capacity cells were realized through a closer working relationship with Lucid and are designed to specifically meet Lucid’s exceptional standards for fast-charging, safety, longevity and performance. Lucid Gravity will be one of the first vehicles to leverage this next-generation cell at scale.

Panasonic Energy, a global leader in lithium-ion batteries, is renowned for its high-quality and high-reliability battery cells. By December 2023, the company had supplied approximately 15 billion lithium-ion EV batteries globally, equivalent to powering 3 million EVs, without any vehicle recalls due to battery-attributed issues. This record further emphasizes Panasonic Energy’s unwavering commitment to quality and safety. Panasonic and Lucid’s collaboration on the Lucid Gravity have further strengthened Lucid’s industry-leading powertrain system.

The partnership between Panasonic Energy and Lucid was established through several multi-year agreements in 2022. Panasonic Energy’s batteries have also been successfully integrated into the award-winning Lucid Air Pure. This success has prompted the adoption of Panasonic’s advanced cylindrical lithium-ion batteries in the Lucid Gravity models as well. The Lucid Gravity Grand Touring, with a starting price of $94,9003, officially started production in December 2024 at Lucid’s vertically integrated factory in Arizona. The Lucid Gravity Touring, which will have a starting price of $79,900 and is planned for late 2025, will also use Panasonic Energy’s 2170 batteries. Panasonic Energy’s 2170 battery cells, key to both models, are produced in Japan, with expected future production at Panasonic’s new production facility in Kansas.

“Lucid Gravity is truly the first SUV that does not force customers to compromise,” said Peter Rawlinson, CEO at Lucid. “It brings together a previously impossible combination of attributes with the interior space of a full-size SUV, the performance of a sports car with supreme comfort, and an EPA rated range of up to 450 miles1. Through our advanced technology and collaboration with Panasonic, we have achieved this with an impressively small battery pack compared to competitors. This is critical to preserving earth’s precious resources and I look forward to our continued work with Panasonic as we further sustainable mobility for the benefit of all.” 

“We are extremely proud of our collaboration with Lucid. By combining our high-performance, high-energy density cells with Lucid’s technology, we have been able to utilize the unique characteristics of our cylindrical cells, resulting in a SUV with unparalleled performance and range. This underscores our continued efforts in aiming to set new standards in the EV industry and contributing to a sustainable society,” said Kazuo Tadanobu, CEO of Panasonic Energy.

About Panasonic Energy

Panasonic Energy Co., Ltd., established in April 2022 as part of the Panasonic Group’s switch to an operating company system, provides innovative battery technology-based products and solutions globally. Through its automotive lithium-ion batteries, storage battery systems and dry batteries, the company brings safe, reliable, and convenient power to a broad range of business areas, from mobility and social infrastructure to medical and consumer products. Panasonic Energy is committed to contributing to a society that realizes happiness and environmental sustainability, and through its business activities the Company aims to address societal issues while taking the lead on environmental initiatives. For more details, please visit https://www.panasonic.com/global/energy/

About Lucid Group

Lucid (NASDAQ: LCID) is a Silicon Valley-based technology company focused on creating the most advanced EVs in the world. The award-winning Lucid Air and new Lucid Gravity deliver best-in-class performance, sophisticated design, expansive interior space and unrivaled energy efficiency. Lucid assembles both vehicles in its state-of-the-art, vertically integrated factory in Arizona. Through its industry-leading technology and innovations, Lucid is advancing the state-of-the-art of EV technology for the benefit of all.

Media Contacts
media@lucidmotors.com 

Forward-Looking Statements
This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “shall,” “expect,” “anticipate,” “believe,” “seek,” “target,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding plans and expectations with respect to Lucid Gravity, including the timing for future trim and its starting price, the promise of Lucid’s partnership with Panasonic, plans and expectations with respect to Panasonic’s battery cell production plans, and the promise of Lucid’s technology. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Lucid’s management. These forward-looking statements are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from these forward-looking statements. Many actual events and circumstances are beyond the control of Lucid. These forward-looking statements are subject to a number of risks and uncertainties, including those factors discussed under the heading “Risk Factors” in Part II, Item 1A of Lucid’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, as well as other documents Lucid has filed or will file with the Securities and Exchange Commission. If any of these risks materialize or Lucid’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Lucid currently does not know or that Lucid currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Lucid’s expectations, plans or forecasts of future events and views as of the date of this communication. Lucid anticipates that subsequent events and developments will cause Lucid’s assessments to change. However, while Lucid may elect to update these forward-looking statements at some point in the future, Lucid specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Lucid’s assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements.

1. EPA est. range rating for Lucid Gravity Grand Touring when equipped with 20″F/21″R wheels and configured as 2-row, 5-seat vehicle is 450 miles. EPA est. range ratings for Lucid Gravity Touring will be provided when available. Range and battery power vary with temperature, driving habits, charging and battery condition and actual results will vary.

2. When configured as a 2-row, 5-seat vehicle.

3. Excludes tax, title, license, options, destination and other fees. For U.S. market only. [Vehicle shown here with optional features]

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-groundbreaking-lucid-gravity-to-leverage-panasonic-energys-latest-generation-high-performance-ev-batteries-302342732.html

SOURCE Lucid Group

Continue Reading

Technology

Zepp Clarity Introduces “Try Before You Buy” OTC Hearing Aids Program at CES 2025, Empowering Consumers with Confidence and Convenience

Published

on

By

MILPITAS, Calif., and LAS VEGAS, Jan. 6, 2025 /PRNewswire/ — Zepp Clarity, the smart hearing solutions brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today unveiled its innovative “Try Before You Buy” program at CES 2025. This initiative addresses a critical gap in hearing aid adoption by encouraging the older population to explore hearing solutions in a low-pressure, hands-on environment.

Despite the widespread prevalence of disabling age-related hearing loss, industry surveys and epidemiological studies have consistently documented that only 15% to 30% of adults with mild-to-moderate hearing loss obtain hearing aids. Many cite uncertainty about their effectiveness or discomfort with the commitment as barriers to adoption.

The “Try Before You Buy” model empowers individuals to experience the transformative benefits of Zepp Clarity’s advanced hearing solutions firsthand, boosting confidence and encouraging greater utilization of hearing aids.

With three state-of-the-art models—Clarity Omni, Clarity One, and Clarity Pixie — Zepp Clarity is redefining hearing care by offering consumers the opportunity to experience advanced hearing solutions through a trial period in their homes.

Zepp Clarity provides a lifetime customer support guarantee and access to certified audiologists to its users, ensuring professional guidance and peace of mind for every customer.

Zepp Clarity Pixie, A Nearly Invisible Hearing Aid Providing A Leap Forward in Technology

At the forefront of Zepp Clarity’s offerings is the Zepp Clarity Pixie, a next-generation hearing aid solution designed for individuals with mild to moderate hearing impairment. The Pixie redefines the hearing aid experience with a nearly invisible design, seamless wireless connectivity, and a lightweight titanium alloy shell. Additional features include IPX7 water resistance, an impressive 17-hour battery life, and the ability to customize settings through the Zepp Clarity App, offering eight unique programs tailored to individual preferences.

The Pixie also includes innovative functionalities such as Clarity Boost, Smart Phone Call support, and a handy Find Device feature, ensuring users can navigate their daily routines with confidence and convenience. With a suggested retail price of $1,499, the Zepp Clarity Pixie is now available at https://clarity.zepp.com.

Empowering Hearing Health for All

Hearing loss impacts 48 million Americans and nearly 430 million people worldwide, yet adoption rates for hearing aids remain low. Zepp Clarity’s mission is to address this critical health challenge by combining cutting-edge wearable technology with expert audiology insights.

Registered as FDA-Exempt Class II medical devices, Zepp Clarity’s hearing aids are meticulously designed to offer discreet, high-performance solutions for adults aged 18 and older, enhancing both their hearing and overall wellness.

About Zepp Clarity

Zepp Clarity, a smart hearing solutions brand under Zepp Health, empowers individuals to live their healthiest lives. Guided by the belief that hearing health is integral to total wellness, Zepp Clarity leverages advanced hearable technologies, AI healthcare algorithms, and the expertise of leading audiologists to create personalized, high-performance hearing systems.

For more information about Zepp Clarity, visit https://clarity.zepp.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/zepp-clarity-introduces-try-before-you-buy-otc-hearing-aids-program-at-ces-2025-empowering-consumers-with-confidence-and-convenience-302342231.html

SOURCE Zepp Health

Continue Reading

Technology

Stage Front Tickets Strengthens Leadership Team with Appointment of Rob McFeaters as CIO and SVP of Technology & Product

Published

on

By

COLUMBIA, Md., Jan. 6, 2025 /PRNewswire/ — Stage Front Tickets, a leading provider of technology platforms that empower ticket brokers of all sizes, today announced the appointment of Rob McFeaters as Chief Information Officer (CIO) and Senior Vice President of Technology & Product. In this newly created role, McFeaters will be responsible for spearheading the company’s technology strategy, driving product innovation, and leading digital transformation initiatives to fuel growth and operational excellence.

McFeaters brings over 20 years of experience in the business services and outsourcing sector to Stage Front Tickets. He joins the company from Element Fleet Management, where he most recently served as VP of IT. In this role, he played a pivotal role in leading successful multi-year business transformations, developing and implementing mobile and web products that enhanced safety and productivity, and overseeing the technical integration and separation of multiple companies. Throughout his career, McFeaters has garnered extensive global experience in business services and artificial intelligence (AI).

Rob McFeaters’ proven track record in business and IT transformation, mergers and acquisitions (M&A), cybersecurity, AI, and software development innovation makes him an ideal addition to our leadership team at Stage Front Tickets,” said Karl Roes, CEO of Stage Front Tickets. “We are confident that his leadership will be instrumental in strengthening our commitment to innovation and creating new value for our customers.”

“I am thrilled to be joining Stage Front Tickets and collaborating with a talented team to drive technology innovation using AI and data to empower our customers with even greater capabilities,” said McFeaters. “Stage Front Tickets’ reputation for pioneering technology innovation in ticket consignment and delivering the industry’s most exceptional customer service aligns perfectly with my passion for customer-centricity and leveraging cutting-edge technologies to “Enhance the client experience and drive business outcomes.”

The appointment of McFeaters underscores Stage Front Tickets’ continued commitment to growth and innovation in the event ticketing space through strategic leadership additions and investments in cutting-edge technology.

About Stage Front Tickets

Stage Front is a leading technology platform designed to empower ticket brokers of all sizes. By providing advanced features such as inventory management, dynamic pricing, sales optimization, and detailed analytics, Stage Front equips its customers with the tools they need to enhance efficiency, maximize profitability, and stay ahead of the curve.

View original content to download multimedia:https://www.prnewswire.com/news-releases/stage-front-tickets-strengthens-leadership-team-with-appointment-of-rob-mcfeaters-as-cio-and-svp-of-technology–product-302343565.html

SOURCE Stage Front

Continue Reading

Trending